Skip to main content
. Author manuscript; available in PMC: 2021 Oct 1.
Published in final edited form as: Arch Toxicol. 2020 Jul 16;94(10):3515–3526. doi: 10.1007/s00204-020-02844-w

Figure 4. Compulsive METH takers exhibit increased p53 but decreased Bcl2 protein levels in the dorsal striatum.

Figure 4.

(A) Differential expression of p53 protein levels in the SR and SS groups. (B) Bcl2 protein levels are decreased only in compulsive METH takers. α-tubulin was used for normalization. Key to statistics: *** P<0.001 vs. CT; $ $ P<0.01 vs. YSR; # P<0.05 vs. SR.